Atrium Health Navicent

Oncology Research, Atrium Health Navicent
777 Hemlock Street, MSC 123
(PACC 800 1st St, Ste 250)
Macon, GA 31201
478-633-3000 (p)
478-633-8894 (f)
www.Atriumhealth.org

driving directions

Clinical Trials

Project: Every Child for Younger Patients with Cancer
Cancer Type: Brain & Spinal Cord Tumor

Project: Every Child for Younger Patients with Cancer
Cancer Type: Brain Tumor

Accelerated or Standard BEP Chemotherapy in Treating Patients with Intermediate or Poor-Risk Metastatic Germ Cell Tumors
Cancer Type: Germ Cell Tumor

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients with Germ Cell Tumors
Cancer Type: Germ Cell Tumor

Project: Every Child for Younger Patients with Cancer
Cancer Type: Leukemia

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients with High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Cancer Type: Leukemia

Project: Every Child for Younger Patients with Cancer
Cancer Type: Neuroendocrine Tumor

Project: Every Child for Younger Patients with Cancer
Cancer Type: Solid Tumor

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents with Cancer
Cancer Type: Solid Tumor

Accelerated or Standard BEP Chemotherapy in Treating Patients with Intermediate or Poor-Risk Metastatic Germ Cell Tumors
Cancer Type: Testicular Cancer

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients with Germ Cell Tumors
Cancer Type: Testicular Cancer

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients with High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Cancer Type: Testicular Cancer

Project: Every Child for Younger Patients with Cancer
Cancer Type: Unknown Primary

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents with Cancer
Cancer Type: Unknown Primary